Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Axonal expression of sodium channels and neuropathology of the plaques in multiple sclerosis.
The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment.
Treatment of sleep disorders may improve fatigue in multiple sclerosis.
Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place?
A report from the American Academy of Neurology 2014 Annual Meeting (April 26-May 3 - Philadelphia, Pennsylvania, USA).
Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis.
[Symptomatic therapy in multiple sclerosis].
Measuring the Impact of Multiple Sclerosis: Enhancing the Performance of the Msis-29 and Msws-12.
Sulforaphane induces Nrf2 target genes and attenuates inflammatory gene expression in microglia from brain of young adult and aged mice.
Transient widespread cortical and splenial lesions in acute encephalitis/encephalopathy associated with primary Epstein-Barr virus infection.
25-hydroxyvitamin D levels are associated with multiple sclerosis in Iran: A cross-sectional study.
Plaque-like demyelination in acute disseminated encephalomyelitis (ADEM) - an autopsy case report.
A logically derived diet to stop MS relapses.
Co-occurring Depression and Pain in Multiple Sclerosis.
The MoSt Project--More Steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy.
Multiple sclerosis and pregnancy; What a neurologist may be asked for?
Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis.
The level of viral infection of antigen-presenting cells is critical for the development of TMEV-induced demyelinating disease.
Relationship between Sleep Quality and Quality of Life in Patients with Multiple Sclerosis.
Correction to Imidazol-1-ylethylindazole Voltage-Gated Sodium Channel Ligands Are Neuroprotective during Optic Neuritis in a Mouse Model of Multiple Sclerosis.
Diagnoses in Pediatric Patients With Magnetic Resonance Imaging (MRI) Lesions Suspicious for Demyelination.
Commentary on Pique et al.'s paper entitled: Peripheral late reactivation of a previously typical monofocal Balo's concentric sclerosis lesion.
Clinical and cognitive implications of cerebrospinal fluid oligoclonal bands in multiple sclerosis patients.
"Central vessel sign" on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine.
Demyelinating CNS Lesions in a Teenager.
Pages
« first
‹ previous
…
604
605
606
607
608
609
610
611
612
…
next ›
last »